Mistletoe in Tumour
Therapy
B A S I C R E S E A R C
H A N D C L I N I C A
L P R A C T I C E
9th
M i s t l e t o e S y m p o s i u
m
4 - 6 November
2027
and
Integrated P r e
s e n c e and O n l i n e F u r
t h e r T r a i n i n g
P r a c t i s e o
f M i s t l e t o e T h e r a p
y
on 5 November 2027, 5.00 -
9.45 p.m.
Europäische Akademie Otzenhausen,
D-66620 Nonnweiler www.eao-otzenhausen.de/en/
1st A n n o u n c e m e n
t
Organizers:
Association of Anthroposophic Doctors in Germany,
Society for Medicinal Plant and Natural Product Research, Society
for Phytotherapy,
Zentralverband der Ärzte für Naturheilverfahren u.
Regulationsmedizin (ZAEN)
Co-operation Partners:
APV The International Association for Pharmaceutical
Technology,
Deutsche Pharmazeutische Gesellschaft (German Pharmaceutical
Society),
European Society for Integrative Oncology
Funding by foundations:
Karl and Veronica Carstens Foundation
Scientific Organizing
Committee:
Dr. Rainer Scheer, Niefern-Öschelbronn
(Director); Prof. Dr. Harald Matthes, Berlin
(Director);
Prof. Dr. Susanne Alban, Kiel; Prof. Dr. Reinhild Klein,
Tübingen; Prof. Dr. Wolfgang Kreis, Hemhofen; PD Dr. Ann-Kathrin
Lederer, Freiburg; PD Dr. Gero Leneweit, Niefern-Öschelbronn; Dr.
Emanuela Portalupi, Mailand (Italien); Sabine Rieger, Balingen; Dr.
Günther Spahn, Mainz; Dr. Rainer Stange, Berlin.
Objectives:
For more than 100 years, tumour patients have been treated with
mistletoe preparations, mostly on an individual basis as part of
integrative oncological care. The aims of mistletoe therapy are
tumour control, support for conventional therapies and their
tolerability, strengthening of the entire organism and improvement
of quality of life. Mistletoe therapy has since been included in
some medical guidelines issued by professional associations. New
findings and therapeutic approaches in oncology are also opening up
new options for the use and further development of mistletoe
therapy. For this reason, the role of mistletoe in tumour therapy
is repeatedly re-examined scientifically at the mistletoe symposia
held every four years. These symposia are intended to provide
scientists and doctors with a forum for discussion and to create a
basis for scientific discourse. The Further Training
Programme is aimed at physicians, pharmacists and all those
involved in the therapy of tumour patients. The organisers would
like to invite you to attend.
This time, the clinical section will focus on the
following topics: Mistletoe in the Context of
Modern Immunotherapies and Multimodal
Therapy Concepts in Integrative Oncology, and the Role of Mistletoe
in such Concepts.
The organizers are calling for current scientific
contributions (short lectures and/or posters) from basic
research and clinical practice of the mistletoe in the tumour
therapy. The box below gives examples of some of the topics
covered:
- Botany, physiology, pharmacy and
phytochemistry: appropriate standardisation,
assurance of pharmaceutical quality of mistletoe preparations,
their analytics and galenic.
- Immunology, pre-clinic, cytotoxicity, mode of
action profile of the active ingredients and total extracts
- Tumour-specific application: for solid and
epithelial tumours, haemoblastoses, for benign tumours, for
recurrence prophylaxis after tumour surgery, for defined
precancerous lesions, influence of mistletoe therapy on
metastasis
- Posology, mode of application: Dosing regimens
and therapeutic range, effects of the route of administration on
the therapeutic range
- Immune parameters before and during mistletoe
therapy; immune status; follow-up parameters for
monitoring mistletoe therapy
- Clinical research and proof of
efficacy: clinical studies with mistletoe, objective
criteria for proof of efficacy, further developments in mistletoe
therapy
- Health services research data/Real World Data
on outcome, tolerability, safety and cost-effectiveness
- Drug safety: analysis of side effects with
regard to effect and efficacy, type and frequency of adverse drug
reactions, pseudo allergic reactions
- Contributions to meta-analyses; systematic
reviews and their evaluation
- Pharmacoeconomics
- Regulatory topics
In order to create a common basis for discussion,
general overview lectures are also planned.
The abstracts of all symposium contributions will be published
in an international scientific journal and will be available online
at the symposium date. All symposium participants will receive
access to the abstracts and, upon request, a printed
copy.
Participation in the Mistletoe Symposium and the hybrid
training programme, cost contribution:
The Mistletoe Symposium will take place in person with a
training programme on Friday, which can also be attended online.
The number of participants and contributions in the scientific part
of the symposium is limited. The decision on the acceptance of
contributions and their form of presentation is the responsibility
of the Scientific Organizing Committee.
No event fees will be charged for participation
in the Mistletoe Symposium. Travel, accommodation and meals
on site must be paid for by each participant.
Language:
The symposium will be held in German. Simultaneous translation
into English will be provided for all presentations, including
contributions to the discussion.
Presentations and posters may also be presented in English.
Publication of conference proceedings:
After the symposium, all contributions will be published in
conference proceedings as soon as possible. We therefore ask
authors to submit a print-ready
manuscript of their contribution by 31
January 2028.
The guidelines for authors of book articles are available at www.mistelsymposium.de.
Continuing education credits:
Certification and accreditation as a continuing education event
by the Saarland Medical Association (Landesärztekammer) and
Saarland Chamber of Pharmacists (Landesapothekerkammer) will also
be applied for the 9th Mistletoe Symposium.
For further information and for written registration
please contact:
Dr. Rainer Scheer, Carl Gustav Carus-Institut, Allmendstr. 55,
D-75223 Niefern-Öschelbronn
Tel. +49 7233 7043-118, Fax +49 7233 7043-110,
E-mail: rainer.scheer@carus-institut.de
Please follow the instructions on our
website www.mistelsymposium.de
Subject to alterations
Niefern-Öschelbronn, December 2025
Dr. Rainer Scheer